RAPT Therapeutics (RAPT) Return on Assets: 2020-2023
Historic Return on Assets for Therapeutics (RAPT) over the last 3 years, with Dec 2023 value amounting to -0.68%.
- Therapeutics' Return on Assets fell 32.00% to -0.68% in Q4 2023 from the same period last year, while for Dec 2023 it was -0.68%, marking a year-over-year decrease of 32.00%. This contributed to the annual value of -0.58% for FY2023, which is 21.00% down from last year.
- Per Therapeutics' latest filing, its Return on Assets stood at -0.68% for Q4 2023, which was down 21.09% from -0.56% recorded in Q3 2023.
- Therapeutics' Return on Assets' 5-year high stood at -0.29% during Q3 2021, with a 5-year trough of -0.68% in Q4 2023.
- In the last 3 years, Therapeutics' Return on Assets had a median value of -0.37% in 2022 and averaged -0.42%.
- As far as peak fluctuations go, Therapeutics' Return on Assets increased by 12bps in 2022, and later plummeted by 32bps in 2023.
- Quarterly analysis of 4 years shows Therapeutics' Return on Assets stood at -0.43% in 2020, then rose by 9bps to -0.33% in 2021, then declined by 3bps to -0.36% in 2022, then crashed by 32bps to -0.68% in 2023.
- Its Return on Assets stands at -0.68% for Q4 2023, versus -0.56% for Q3 2023 and -0.45% for Q2 2023.